Found 12 matching trials
Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464
PHASE1A two part, fixed-sequence, open-label crossover study to evaluate potentia...
Safety and Pharmacokinetics Study in Healthy Japanese Volunteers
PHASE1The study consists of Part A, a randomized double-blind, single-ascending-d...
Location
Medical Corporation Heishinkai OPHAC Hospital
ABX464 First in Man Study
PHASE1This study is an open label, parallel group, single ascending dose, explora...
ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
PHASE2This Phase IIa study is an 8-week, double-blind, placebo-controlled, random...
Location
Univ.-Klinik für Innere Medizin I
A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
PHASE1The purpose of the ABX464-005 study is to characterize the systemic and muc...
Location
Hospital Universitari Germans Trias i Pujol
ABTECT - Maintenance
PHASE3This is a multicenter, randomized, placebo-controlled study to evaluate the...
Status
Active Not Recruiting
Location
Digestive Health Specialists of the Southeast
Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis
PHASE2A phase 2a open-label study to evaluate the long-term safety and efficacy o...
Location
Cliniques Universitaires Saint-Luc
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
PHASE2Phase 2b study to evaluate the efficacy and the safety of 3 dose-levels of ...
Location
UCSD Health System
Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis
PHASE2This study is an open-label study aiming at evaluating the long-term safety...
Location
Department of Gastroenterology - University hospitals Leuven
Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
PHASE2A phase 2b study to evaluate the long-term efficacy and safety study of ABX...
Location
Medizinische Universität Innsbruck